Index RUT P/E 22.82 EPS (ttm) 3.52 Insider Own 2.96% Shs Outstand 69.15M Perf Week -0.40%
Market Cap 5.56B Forward P/E 10.84 EPS next Y 7.42 Insider Trans -7.07% Shs Float 67.14M Perf Month 3.51%
Enterprise Value 5.24B PEG 2.73 EPS next Q 1.67 Inst Own 114.92% Short Float 13.60% Perf Quarter -17.45%
Income 254.32M P/S 3.62 EPS this Y -1.77% Inst Trans 6.84% Short Ratio 8.06 Perf Half Y -9.77%
Sales 1.54B P/B 4.78 EPS next Y 11.76% ROA 13.09% Short Interest 9.13M Perf YTD -10.11%
Book/sh 16.84 P/C 5.93 EPS next 5Y 8.36% ROE 24.11% 52W High 126.89 -36.62% Perf Year 0.52%
Cash/sh 13.57 P/FCF 11.82 EPS past 3/5Y - 40.75% ROIC 14.30% 52W Low 73.11 10.00% Perf 3Y 26.09%
Dividend Est. - EV/EBITDA 10.27 Sales past 3/5Y 53.37% 34.59% Gross Margin 64.04% Volatility 2.62% 3.00% Perf 5Y 503.75%
Dividend TTM - EV/Sales 3.41 EPS Y/Y TTM -45.33% Oper. Margin 29.12% ATR (14) 2.47 Perf 10Y 1087.89%
Dividend Ex-Date - Quick Ratio 5.46 Sales Y/Y TTM 12.53% Profit Margin 16.55% RSI (14) 48.55 Recom 1.15
Dividend Gr. 3/5Y - - Current Ratio 5.74 EPS Q/Q -45.41% SMA20 0.27% Beta 0.16 Target Price 128.31
Payout 0.00% Debt/Eq 0.53 Sales Q/Q 0.75% SMA50 -4.36% Rel Volume 0.29 Prev Close 79.62
Employees 808 LT Debt/Eq 0.53 Earnings May 07 BMO SMA200 -14.09% Avg Volume 1.13M Price 80.42
IPO Jun 25, 2015 Option/Short Yes / Yes EPS/Sales Surpr. -7.65% -1.82% Trades
Volume 329,518 Change 1.00%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-24 Initiated Goldman
Buy
$143
Sep-03-24 Initiated Redburn Atlantic
Buy
$175
Jul-10-24 Reiterated JMP Securities
Mkt Outperform
$100 → $130
Dec-18-23 Downgrade William Blair
Outperform → Mkt Perform
Dec-04-23 Initiated TD Cowen
Outperform
$100
Sep-29-23 Initiated William Blair
Outperform
Mar-08-23 Initiated JMP Securities
Mkt Outperform
$120
Nov-30-22 Initiated SVB Leerink
Outperform
Oct-13-22 Initiated Mizuho
Buy
$105
May-09-22 Initiated B. Riley Securities
Buy
$91
Apr-13-22 Initiated Truist
Buy
$77
Feb-01-21 Initiated SVB Leerink
Outperform
$24
Jun-29-20 Resumed Jefferies
Buy
$29
Aug-16-19 Upgrade CJS Securities
Market Perform → Market Outperform
Nov-02-17 Upgrade Wells Fargo
Market Perform → Outperform
Nov-08-16 Reiterated RBC Capital Mkts
Outperform
$6 → $12
Sep-23-16 Resumed Credit Suisse
Neutral
Feb-24-16 Reiterated RBC Capital Mkts
Outperform
$9 → $6
Dec-11-15 Downgrade Credit Suisse
Outperform → Neutral
Sep-30-15 Downgrade Wells Fargo
Outperform → Market Perform
Show Previous Ratings
Jul-03-25 12:34AM
Jul-02-25 01:35AM
Jun-29-25 09:56PM
Jun-28-25 04:16AM
Jun-24-25 03:09PM
11:31PM
Loading…
Jun-23-25 11:31PM
Jun-11-25 04:01PM
Jun-10-25 08:30AM
Jun-03-25 08:30AM
Jun-02-25 08:00AM
May-14-25 08:30AM
May-09-25 10:32AM
May-08-25 06:20AM
05:03AM
03:09AM
12:49AM
Loading…
12:49AM
(Thomson Reuters StreetEvents)
May-07-25 12:01PM
11:26AM
11:23AM
07:22AM
(Associated Press Finance)
07:00AM
May-06-25 04:01PM
06:20AM
Apr-30-25 08:30AM
Apr-27-25 03:29PM
Apr-23-25 08:30AM
Apr-19-25 05:30AM
Apr-09-25 12:57PM
Apr-01-25 09:00AM
Mar-27-25 12:03PM
12:00PM
Loading…
Mar-23-25 12:00PM
Mar-20-25 12:00PM
Mar-14-25 12:10PM
Mar-10-25 05:01AM
Feb-27-25 02:06AM
Feb-26-25 10:35PM
(Thomson Reuters StreetEvents) +16.49%
01:06PM
08:06AM
07:20AM
(Associated Press Finance)
07:00AM
Feb-25-25 10:14AM
08:04AM
Feb-21-25 08:30AM
Feb-20-25 03:07PM
Feb-12-25 08:00AM
Feb-05-25 08:30AM
Feb-04-25 12:41PM
Feb-03-25 04:40PM
(Pharmaceutical Technology)
Jan-30-25 08:30AM
Jan-29-25 01:32PM
10:41AM
(Pharmaceutical Technology)
04:30AM
Jan-28-25 10:32AM
06:30AM
Jan-27-25 11:04AM
(Pharmaceutical Technology)
Jan-14-25 11:28AM
Jan-13-25 12:05AM
Jan-07-25 08:08AM
03:00AM
(Investor's Business Daily)
Dec-16-24 05:21PM
Dec-01-24 09:08AM
Nov-27-24 08:12AM
Nov-20-24 06:54PM
01:00AM
Nov-13-24 08:30AM
Nov-11-24 07:39AM
Nov-07-24 02:08AM
02:04AM
(Thomson Reuters StreetEvents)
Nov-06-24 07:13AM
(Associated Press Finance) -20.69%
07:00AM
Nov-05-24 07:38AM
Nov-04-24 07:30AM
Nov-01-24 03:31AM
Oct-23-24 08:30AM
Oct-18-24 06:28AM
Oct-12-24 01:05PM
Sep-25-24 10:00AM
(Investor's Business Daily)
07:47AM
Sep-19-24 12:08PM
Sep-15-24 08:45AM
Sep-05-24 08:30AM
Aug-28-24 08:30AM
Aug-20-24 08:30AM
Aug-14-24 07:01PM
Jul-31-24 07:13AM
(Associated Press Finance)
07:00AM
Jul-23-24 03:52AM
Jul-17-24 08:30AM
Jul-15-24 08:30AM
Jul-10-24 04:11PM
(Investor's Business Daily) +36.65%
+16.42%
12:32PM
11:57AM
Jul-08-24 08:30AM
Jul-05-24 06:48AM
Jul-04-24 07:47AM
Jun-27-24 07:05AM
Jun-24-24 09:50AM
Jun-20-24 08:41PM
Jun-18-24 06:15PM
11:47AM
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Niedzwiecki Daniel See Remarks Jun 13 '25 Sale 78.74 6,000 472,440 87,057 Jun 17 04:31 PM Niedzwiecki Daniel Officer Jun 13 '25 Proposed Sale 78.74 6,000 472,440 Jun 13 10:00 AM McHugh Julie Director Jun 09 '25 Sale 81.62 5,192 423,771 25,962 Jun 11 04:33 PM Marshall Robert J. Jr. CFO and Treasurer Jun 09 '25 Option Exercise 49.93 14,773 737,616 128,633 Jun 11 04:32 PM Marshall Robert J. Jr. CFO and Treasurer Jun 09 '25 Sale 83.00 39,773 3,301,296 88,860 Jun 11 04:32 PM Blanchfield Paul President Jun 05 '25 Sale 79.65 6,599 525,610 111,792 Jun 09 04:34 PM Niedzwiecki Daniel See Remarks Jun 05 '25 Sale 79.65 6,000 477,900 93,057 Jun 09 04:34 PM Marshall Robert J. Jr. Officer Jun 09 '25 Proposed Sale 81.62 39,773 3,246,272 Jun 09 11:11 AM McHugh Julie Director Jun 09 '25 Proposed Sale 81.62 5,192 423,771 Jun 09 10:06 AM Heino Mary Anne Director Jun 02 '25 Proposed Sale 76.73 26,066 1,999,957 Jun 05 12:35 PM Blanchfield Paul Officer Jun 05 '25 Proposed Sale 79.65 6,599 525,610 Jun 05 11:23 AM Niedzwiecki Daniel Officer Jun 05 '25 Proposed Sale 79.65 6,000 477,900 Jun 05 10:13 AM Heino Mary Anne Director Jun 02 '25 Sale 76.83 26,066 2,002,570 318,650 Jun 04 04:32 PM Marshall Robert J. Jr. CFO and Treasurer Mar 17 '25 Sale 100.52 10,000 1,005,200 113,860 Mar 19 06:44 PM Heino Mary Anne Director Mar 13 '25 Sale 100.13 2 200 8,618 Mar 17 08:09 PM Marshall Robert J. Jr. Officer Mar 17 '25 Proposed Sale 100.52 10,000 1,005,200 Mar 17 10:49 AM Blanchfield Paul President Mar 05 '25 Sale 98.00 2,084 204,232 91,828 Mar 07 05:44 PM Heino Mary Anne Director Mar 03 '25 Sale 94.35 53,107 5,010,734 440,399 Mar 05 05:09 PM Blanchfield Paul Officer Mar 05 '25 Proposed Sale 98.00 2,084 204,232 Mar 05 10:17 AM Heino Mary Anne Officer Mar 03 '25 Proposed Sale 91.00 53,200 4,841,200 Feb 28 03:31 PM Thrall James H Director Jan 15 '25 Sale 94.76 1,000 94,760 33,207 Jan 17 04:15 PM Thrall James H Director Jan 15 '25 Proposed Sale 94.76 1,000 94,760 Jan 15 09:59 AM MARKISON BRIAN A CEO Dec 19 '24 Option Exercise 9.15 32,768 299,983 185,594 Dec 23 07:33 PM Marshall Robert J. Jr. CFO and Treasurer Nov 15 '24 Sale 81.20 10,000 812,000 102,963 Nov 19 04:39 PM Blanchfield Paul President Nov 14 '24 Sale 79.65 2,000 159,300 97,092 Nov 18 05:36 PM Marshall Robert J. Jr. Officer Nov 15 '24 Proposed Sale 81.20 10,000 812,000 Nov 15 11:59 AM Blanchfield Paul Officer Nov 14 '24 Proposed Sale 79.65 2,000 159,300 Nov 14 10:07 AM Heino Mary Anne Director Nov 08 '24 Sale 87.16 11,487 1,001,218 443,436 Nov 12 05:41 PM Heino Mary Anne Officer Nov 08 '24 Proposed Sale 87.06 11,487 1,000,060 Nov 08 04:38 PM Sabens Andrea Officer Oct 14 '24 Proposed Sale 113.10 342 38,680 Oct 15 08:28 AM Sabens Andrea Officer Sep 13 '24 Proposed Sale 104.10 341 35,498 Sep 13 01:29 PM Thrall James H Director Aug 21 '24 Sale 98.52 1,000 98,520 34,207 Aug 23 04:30 PM Thrall James H Director Aug 21 '24 Proposed Sale 98.52 1,000 98,520 Aug 21 09:51 AM Niedzwiecki Daniel See Remarks Aug 14 '24 Sale 97.54 2,500 243,850 77,744 Aug 16 04:30 PM Ber Gerard Director Aug 12 '24 Sale 96.48 15,500 1,495,396 21,221 Aug 14 04:56 PM Niedzwiecki Daniel Officer Aug 14 '24 Proposed Sale 97.54 2,500 243,850 Aug 14 12:41 PM Sabens Andrea Officer Aug 13 '24 Proposed Sale 97.83 341 33,360 Aug 13 10:59 AM Blanchfield Paul President Aug 08 '24 Sale 96.39 2,000 192,780 98,980 Aug 12 05:09 PM Gerard Ber Director Aug 12 '24 Proposed Sale 97.33 15,500 1,508,615 Aug 12 04:23 PM Blanchfield Paul Officer Aug 08 '24 Proposed Sale 96.39 2,000 192,780 Aug 08 11:16 AM Heino Mary Anne Director Aug 02 '24 Sale 95.50 10,481 1,000,900 454,923 Aug 06 04:30 PM Heino Mary Anne Officer Aug 02 '24 Proposed Sale 95.42 10,481 1,000,115 Aug 02 04:21 PM Sabens Andrea Chief Accounting Officer Jul 16 '24 Sale 124.96 1,796 224,423 60,420 Jul 17 04:30 PM Sabens Andrea Chief Accounting Officer Jul 15 '24 Sale 123.15 341 41,994 62,216 Jul 17 04:30 PM Pruden Gary J Director Jul 10 '24 Sale 95.04 12,530 1,190,851 11,978 Jul 12 04:30 PM
